Effects of pharmacological serum from normal and liver fibrotic rats on HSCs

Table 1 Inhibitory rate of drug sera on the proliferation of HSC (MTT).

Group	IR (%)	A	Group	IR (%)	A
A1	33.62±0.72a	0.42±0.08a	B1	47.42±0.17ce	0.33±0.02ce
A2	49.74±1.02a	0.32±0.10a	B2	58.12±1.04ce	0.26±0.01ce
A3	29.38±0.75	0.45±0.12	B3	34.66±0.78	0.41±0.09
A4	-	0.64±0.08	B4	-	0.62±0.11

^aP<0.05 vs group A3 and A4 A(mean±SD);

^cP<0.05 vs group B3 and B4;

^eP<0.05 vs group A1 and A2, respectively; IR = (A_{experiment group}-A_{control group}) ÷A_{control group}×100%.

Table 2 Effect of drug sera on the expression of α-SMA in HSC (%).

Group	αSMA	Group	αSMA
A1	41.72±1.48a	B1	37.13±2.42ce
A2	37.00±0.45a	B2	32.13±1.46ce
A3	48.13±1.08	B3	46.12±0.48
A4	64.10±2.85	B4	60.88±2.07

^aP<0.05 vs group A3 and A4;

^cP<0.05 vs group B3 and B4;

^eP<0.05 vs group A1 and A2, respectively; α-SMA (number of positive HSCs ÷ number of all HSCs ×100%).